Cargando…
Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients
BACKGROUND: Complement plays a pivotal role in the immune response to infection. Several studies demonstrated complement activation in sepsis, yet little is known of the relationship of complement terminal pathway activation and the clinical characteristics of sepsis patients. Therefore, we investig...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760944/ https://www.ncbi.nlm.nih.gov/pubmed/35046691 http://dx.doi.org/10.2147/JIR.S344282 |
_version_ | 1784633428261470208 |
---|---|
author | Ahmad, Fatima M A Al-Binni, Maysaa’ Bani Hani, Amjad Abu Abeeleh, Mahmoud Abu-Humaidan, Anas H A |
author_facet | Ahmad, Fatima M A Al-Binni, Maysaa’ Bani Hani, Amjad Abu Abeeleh, Mahmoud Abu-Humaidan, Anas H A |
author_sort | Ahmad, Fatima M |
collection | PubMed |
description | BACKGROUND: Complement plays a pivotal role in the immune response to infection. Several studies demonstrated complement activation in sepsis, yet little is known of the relationship of complement terminal pathway activation and the clinical characteristics of sepsis patients. Therefore, we investigated serum C5, soluble C5b-9 (sC5b-9), and soluble CD59 (sCD59) and their relation to organ failure in sepsis patients in the intensive care unit (ICU). METHODS: In this prospective cohort study, all available patients admitted to the adult ICUs between June 2020 and January 2021 were included. Patients were divided into sepsis and non-sepsis groups according to the Sepsis-3 criteria, serum samples from both groups were investigated for the levels of C5, sC5b-9, and sCD59 using commercial sandwich ELISA kits. RESULTS: We analyzed 79 serum samples, 36 were from sepsis patients. We found that sepsis patients had significantly lower C5 (83.6± 28.4 vs 104.4± 32.0 µg/mL, p = 0.004) and higher sCD59 (380.7± 170.5 vs 288.9± 92.5 ng/mL, p = 0.016). sC5b-9, although higher in sepsis patients, did not reach statistical significance (1.5± 0.8 µg/mL vs 1.3± 0.7 µg/mL, p = 0.293). Sepsis patients who died during their ICU stay had significantly higher sCD59 compared to those who survived (437.0 ± 176.7 vs 267.8 ± 79.7 ng/mL, p = 0.003, respectively). Additionally, C5 and sCD59 both correlated to SOFA score in the sepsis group (r(s) = −0.44, P = 0.007 and = 0.43, P = 0.009, respectively), and a similar correlation was not found in the non-sepsis group. DISCUSSION: In sepsis patients, levels of C5 and sCD59, but not sC5b-9, correlated to the severity of organ damage measured by SOFA. A similar correlation was not found in non-sepsis patients. This indicated that organ damage associated with sepsis led to a more pronounced terminal pathway activation than in non-sepsis patients, it also indicated the potential of using C5 and sCD59 to reflect sepsis severity. |
format | Online Article Text |
id | pubmed-8760944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-87609442022-01-18 Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients Ahmad, Fatima M A Al-Binni, Maysaa’ Bani Hani, Amjad Abu Abeeleh, Mahmoud Abu-Humaidan, Anas H A J Inflamm Res Original Research BACKGROUND: Complement plays a pivotal role in the immune response to infection. Several studies demonstrated complement activation in sepsis, yet little is known of the relationship of complement terminal pathway activation and the clinical characteristics of sepsis patients. Therefore, we investigated serum C5, soluble C5b-9 (sC5b-9), and soluble CD59 (sCD59) and their relation to organ failure in sepsis patients in the intensive care unit (ICU). METHODS: In this prospective cohort study, all available patients admitted to the adult ICUs between June 2020 and January 2021 were included. Patients were divided into sepsis and non-sepsis groups according to the Sepsis-3 criteria, serum samples from both groups were investigated for the levels of C5, sC5b-9, and sCD59 using commercial sandwich ELISA kits. RESULTS: We analyzed 79 serum samples, 36 were from sepsis patients. We found that sepsis patients had significantly lower C5 (83.6± 28.4 vs 104.4± 32.0 µg/mL, p = 0.004) and higher sCD59 (380.7± 170.5 vs 288.9± 92.5 ng/mL, p = 0.016). sC5b-9, although higher in sepsis patients, did not reach statistical significance (1.5± 0.8 µg/mL vs 1.3± 0.7 µg/mL, p = 0.293). Sepsis patients who died during their ICU stay had significantly higher sCD59 compared to those who survived (437.0 ± 176.7 vs 267.8 ± 79.7 ng/mL, p = 0.003, respectively). Additionally, C5 and sCD59 both correlated to SOFA score in the sepsis group (r(s) = −0.44, P = 0.007 and = 0.43, P = 0.009, respectively), and a similar correlation was not found in the non-sepsis group. DISCUSSION: In sepsis patients, levels of C5 and sCD59, but not sC5b-9, correlated to the severity of organ damage measured by SOFA. A similar correlation was not found in non-sepsis patients. This indicated that organ damage associated with sepsis led to a more pronounced terminal pathway activation than in non-sepsis patients, it also indicated the potential of using C5 and sCD59 to reflect sepsis severity. Dove 2022-01-08 /pmc/articles/PMC8760944/ /pubmed/35046691 http://dx.doi.org/10.2147/JIR.S344282 Text en © 2022 Ahmad et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Ahmad, Fatima M A Al-Binni, Maysaa’ Bani Hani, Amjad Abu Abeeleh, Mahmoud Abu-Humaidan, Anas H A Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients |
title | Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients |
title_full | Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients |
title_fullStr | Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients |
title_full_unstemmed | Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients |
title_short | Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients |
title_sort | complement terminal pathway activation is associated with organ failure in sepsis patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760944/ https://www.ncbi.nlm.nih.gov/pubmed/35046691 http://dx.doi.org/10.2147/JIR.S344282 |
work_keys_str_mv | AT ahmadfatimam complementterminalpathwayactivationisassociatedwithorganfailureinsepsispatients AT aalbinnimaysaa complementterminalpathwayactivationisassociatedwithorganfailureinsepsispatients AT banihaniamjad complementterminalpathwayactivationisassociatedwithorganfailureinsepsispatients AT abuabeelehmahmoud complementterminalpathwayactivationisassociatedwithorganfailureinsepsispatients AT abuhumaidananasha complementterminalpathwayactivationisassociatedwithorganfailureinsepsispatients |